Drug repurposing (also called drug repositioning or drug re-profiling) is a strategy for identifying new uses for approved or investigational drugs that are outside the ambit of the original medical indication. This strategy offers various benefits over developing an entirely new drug for a given indication.

Research currently being undertaken by the Centre for Drug Repurposing and Medicines Research includes:

  • ACRE – The Australian Centre for Cannabinoid Clinical and Research Excellence is a National Health and Medical Research Council Centre of Research Excellence.
  • NSW Health cannabis trials – Australian-based clinical trials in cannabinoids currently managed by ACRE Investigators and our Affiliated Researchers.
  • PREDICT – Therapeutic drug monitoring to optimise cancer treatments (developing drugs to their full potential).
  • Developing technology – e.g. small volume sampling methods.
  • Theranostics – Developing research staff and delivering Investigator-initiated clinical trials to develop new therapeutic areas.
  • Drug repurposing -  Developing research staff and pre-clinical data for Investigator-initiated clinical trials to repurpose established therapeutics for new indications.